GlassScriptPhysician profile
Carrie Lea Evans
NPI 1821681198
$1,084.74
in general payments reported to CMS, 2019-2025
24 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $324 · 2023: $282 · 2024: $119 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $260.53 | 2023-2025 | Fintepla |
| Astrazeneca Pharmaceuticals LP | $115.24 | 2022 | |
| Akcea Therapeutics, INC. | $106.50 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $97.20 | 2023 | Cinryze |
| Regeneron Healthcare Solutions, INC. | $61.81 | 2022 | |
| Lilly USA, LLC | $53.56 | 2025 | Zepbound |
| Novo Nordisk INC | $41.18 | 2021-2022 | |
| Alk-Abello, INC | $41.10 | 2022 | |
| Avion Pharmaceuticals | $35.67 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.99 | 2021 | |
| Genzyme Corporation | $24.42 | 2023 | |
| Csl Behring | $22.68 | 2023 | Hizentra |
| Boston Scientific Corporation | $22.41 | 2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $20.43 | 2022 | |
| Scilex Pharmaceuticals INC. | $20.24 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $19.87 | 2023 | Adlarity |
| Neurelis, INC. | $19.34 | 2023 | Valtoco |
| Amneal Pharmaceuticals LLC | $17.79 | 2022 | |
| Harmony Biosciences LLC | $16.04 | 2025 | |
| Amgen INC. | $15.02 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.84 | 2021 | |
| Kaleo, INC. | $12.73 | 2023 | Auvi-Q |
| Biohaven Pharmaceuticals, INC. | $11.49 | 2021 | |
| Genentech USA, INC. | $3.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.